Securities fraud litigation history and active cases
In Litigation
0
Settlement
0
Closed
1
Total Settlement
$40M
8:21cv955 • April 19, 2021
Class Period Start
March 9, 2020
Class Period End
February 2, 2022
PSLRA Deadline
June 21, 2021
Case Allegations
10b5
Statutes of Repose
Mar 9, 2023
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
February 4, 2025
Settlement Fund
$40,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased or otherwise acquired the common stock of Emergent BioSolutions Inc. (“Emergent”) (NYSE: EBS) between March 10, 2020 and November 4, 2021, both dates inclusive.
Claim Administrator
Strategic Claims Services
P.O. Box 230, 600 N. Jackson St., Ste. 205 Media, PA 19063
+1 866-274-4004
[email protected]
Settlement Website
https://www.strategicclaims.net/emergent/Hearing Date
February 27, 2025
Opt-out Deadline
February 4, 2025
Settlement Note
Download hereProof Of Claim
Download here
Jul 3, 2025
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Feb 27, 2025
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Feb 6, 2025
Motion for Final Approval of Settlement
The parties have asked the court to grant final approval of the proposed settlement. The judge will consider whether the settlement should be approved after reviewing the settlement terms and any objections. If approved, eligible investors who submit valid claims may receive a payment after the claims review and distribution process is completed.
Oct 16, 2024
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 16, 2024
Notice of Pendency
TOP
